Skip to main content

Table 1 Characteristics of the study subjects by BBIBP-CorV vaccination status, Morocco, 1 February 2021 through 30 June 2021

From: Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco

 

Not Vaccinated

N = 206,149

Fully Vaccinated

N = 140,892

Booster-vaccinated

N = 1,149

Total

N = 348,190

Sex, n (%)

 Male

116,816 (56.7)

81,580 (57.9)

1,024 (89.1)

199,420 (57.3)

 Female

89,333 (43.3)

59,312 (42.1)

125 (10.9)

148,770 (42.7)

Age (Years)

 Mean (SD)

40.7 (15.1)

37.9 (13.5)

45.1 (15.8)

39.6 (14.6)

Age group (Years), n (%)

 18–29

56,553 (27.4)

47,313 (33.6)

201 (17.5)

104,067 (29.9)

 30–39

53,558 (26.0)

35,226 (25.0)

336 (29.2)

89,120 (25.6)

 40–49

41,896 (20.3)

29,515 (20.9)

195 (17.0)

71,606 (20.5)

 50–59

27,576 (13.4)

21,263 (15.1)

151 (13.1)

48,990 (14.1)

 >  = 60

26,566 (12.9)

7,575 (5.4)

266 (23.2)

34,407 (9.9)

  1. N (%) refer to numbers and percentages of each group
  2. Abbreviations: SD Standard deviation